143 related articles for article (PubMed ID: 29652926)
21. Identification and cost of adverse events in metastatic breast cancer in taxane and capecitabine based regimens.
Hansen RN; Ramsey SD; Lalla D; Masaquel A; Kamath T; Brammer M; Hurvitz SA; Sullivan SD
Springerplus; 2014; 3():259. PubMed ID: 24926422
[TBL] [Abstract][Full Text] [Related]
22. Prevalence and healthcare costs of obesity-related comorbidities: evidence from an electronic medical records system in the United States.
Li Q; Blume SW; Huang JC; Hammer M; Ganz ML
J Med Econ; 2015; 18(12):1020-8. PubMed ID: 26134917
[TBL] [Abstract][Full Text] [Related]
23. The economic burden of lung cancer and the associated costs of treatment failure in the United States.
Kutikova L; Bowman L; Chang S; Long SR; Obasaju C; Crown WH
Lung Cancer; 2005 Nov; 50(2):143-54. PubMed ID: 16112249
[TBL] [Abstract][Full Text] [Related]
24. Incidence, direct costs and duration of hospitalization of patients hospitalized with community acquired pneumonia: A nationwide retrospective claims database analysis.
Rozenbaum MH; Mangen MJ; Huijts SM; van der Werf TS; Postma MJ
Vaccine; 2015 Jun; 33(28):3193-9. PubMed ID: 25981488
[TBL] [Abstract][Full Text] [Related]
25. Cost-utility analysis of duloxetine in osteoarthritis: a US private payer perspective.
Wielage RC; Bansal M; Andrews JS; Klein RW; Happich M
Appl Health Econ Health Policy; 2013 Jun; 11(3):219-36. PubMed ID: 23616247
[TBL] [Abstract][Full Text] [Related]
26. Clinical and economic outcomes of Staphylococcus aureus septicemia in ESRD patients receiving hemodialysis.
Nissenson AR; Dylan ML; Griffiths RI; Yu HT; Dean BB; Danese MD; Dubois RW
Am J Kidney Dis; 2005 Aug; 46(2):301-8. PubMed ID: 16112049
[TBL] [Abstract][Full Text] [Related]
27. Economic Burden of HIV Antiretroviral Therapy Adverse Events in the United States.
Dekoven M; Makin C; Slaff S; Marcus M; Maiese EM
J Int Assoc Provid AIDS Care; 2016; 15(1):66-76. PubMed ID: 26224690
[TBL] [Abstract][Full Text] [Related]
28. Incidence of acute care adverse events and long-term health-related quality of life in patients with TSCI.
Street JT; Noonan VK; Cheung A; Fisher CG; Dvorak MF
Spine J; 2015 May; 15(5):923-32. PubMed ID: 23981816
[TBL] [Abstract][Full Text] [Related]
29. Comorbidity burden, healthcare resource utilization, and costs in chronic gout patients refractory to conventional urate-lowering therapy.
Wu EQ; Forsythe A; Guérin A; Yu AP; Latremouille-Viau D; Tsaneva M
Am J Ther; 2012 Nov; 19(6):e157-66. PubMed ID: 21317625
[TBL] [Abstract][Full Text] [Related]
30. Economic burden of adverse events in patients with metastatic renal cell carcinoma.
Hagiwara M; Borker R; Oster G
Clin Ther; 2013 Dec; 35(12):1955-1963.e2. PubMed ID: 24290735
[TBL] [Abstract][Full Text] [Related]
31. Increased Prevalence of Cancer in Adult Patients With Psoriasis in the United States: A Claims Based Analysis.
Kimball AB; Sundaram M; Cloutier M; Gauthier-Loiselle M; Gagnon-Sanschagrin P; Guérin A; Ganguli A
J Drugs Dermatol; 2018 Feb; 17(2):180-186. PubMed ID: 29462226
[TBL] [Abstract][Full Text] [Related]
32. Burden of corticosteroid use in patients with systemic lupus erythematosus: results from a Delphi panel.
Petri M; Bechtel B; Dennis G; Shah M; McLaughlin T; Kan H; Molta C
Lupus; 2014 Sep; 23(10):1006-13. PubMed ID: 24786783
[TBL] [Abstract][Full Text] [Related]
33. Real-world Direct Health Care Costs for Metastatic Colorectal Cancer Patients Treated With Cetuximab or Bevacizumab-containing Regimens in First-line or First-line Through Second-line Therapy.
Johnston S; Wilson K; Varker H; Malangone-Monaco E; Juneau P; Riehle E; Satram-Hoang S; Sommer N; Ogale S
Clin Colorectal Cancer; 2017 Dec; 16(4):386-396.e1. PubMed ID: 28619608
[TBL] [Abstract][Full Text] [Related]
34. Comparative treatment-related adverse event cost burden in immune thrombocytopenic purpura.
Donga PZ; Bilir SP; Little G; Babinchak T; Munakata J
J Med Econ; 2017 Nov; 20(11):1200-1206. PubMed ID: 28882075
[TBL] [Abstract][Full Text] [Related]
35. Time-Dependent and Immunosuppressive Drug-Associated Adverse Event Profiles in De Novo Kidney Transplant Recipients Converted from Tacrolimus to Sirolimus Regimens.
Felix MJ; Felipe CR; Tedesco-Silva H; Osmar Medina-Pestana J
Pharmacotherapy; 2016 Feb; 36(2):152-65. PubMed ID: 26799522
[TBL] [Abstract][Full Text] [Related]
36. Epidemiology and economic burden of brain metastases among patients with primary breast cancer: results from a US claims data analysis.
Pelletier EM; Shim B; Goodman S; Amonkar MM
Breast Cancer Res Treat; 2008 Mar; 108(2):297-305. PubMed ID: 17577662
[TBL] [Abstract][Full Text] [Related]
37. Clinical characteristics, treatment patterns, and economic burden in patients treated for neuroendocrine tumors in the United States: a retrospective cohort study.
Chuang CC; Bhurke S; Chen SY; Brulais S; Gabriel S
J Med Econ; 2015 Feb; 18(2):126-36. PubMed ID: 25325180
[TBL] [Abstract][Full Text] [Related]
38. Economic burden of non-cystic fibrosis bronchiectasis in the first year after diagnosis from a US health plan perspective.
Joish VN; Spilsbury-Cantalupo M; Operschall E; Luong B; Boklage S
Appl Health Econ Health Policy; 2013 Jun; 11(3):299-304. PubMed ID: 23580074
[TBL] [Abstract][Full Text] [Related]
39. Attention to cancer patients' safety after primary treatment is needed.
Christiansen AH; Lipczak H; Knudsen JL
Dan Med J; 2015 Jun; 62(6):. PubMed ID: 26036885
[TBL] [Abstract][Full Text] [Related]
40. Economic burden associated with patients diagnosed with hepatitis C.
McCombs JS; Yuan Y; Shin J; Saab S
Clin Ther; 2011 Sep; 33(9):1268-80. PubMed ID: 21840056
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
